EMO Health | Strategic Alliance Partners

Pharmacy Times interviews Allison Burns, PharmD, RPh, the CEO of End Mass Overdose (EMO) Health to discuss how stigma from health care providers or frontline staff impacts patient willingness to seek or continue treatment.

Pharmacy Times interviews Allison Burns, PharmD, RPh, the CEO of End Mass Overdose (EMO) Health to discuss common myths and misconceptions surrounding antidepressants, antipsychotics, and medications for addiction treatment in congregate care settings.

Brian Anderson, PharmD, RPh provides important considerations for pharmacists regarding patient use of benzodiazepines.

Pharmacists receive 3 years of funding to improve medication safety for homeless and unhoused community members

Allison Burns discusses how pharmacists should prepare and educate themselves regarding OTC naloxone, and the steps that can be taken in stores and pharmacies to ensure OTC naloxone is visible and available.

Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.

Community pharmacists’ influence increases the likelihood of patients safely disposing unused medications and keeping them out of harm’s reach.

Taking pharmacists out of the dispensing setting and placing them in communities as educators on drug safety is reaping rewards.

Allison Burns, Pharm.D., RPh, honored as the 2020 Next-Generation Pharmacist®.